myasthenia gravis

/Tag:myasthenia gravis

A CASE OF PEMBROLIZUMAB-INDUCED COMPLETE HEART BLOCK AND MYASTHENIA GRAVIS

Case Presentation: A 60-year-old man with coronary artery disease and metastatic renal cell carcinoma presents with worsening dyspnea on exertion 3 weeks after his first infusion of pembrolizumab. On presentation, he was tachycardic and in [...]

By | 2018-03-19T15:44:29+00:00 March 19th, 2018|Adult, Clinical Vignettes, Uncategorized|Comments Off on A CASE OF PEMBROLIZUMAB-INDUCED COMPLETE HEART BLOCK AND MYASTHENIA GRAVIS

ASSOCIATION BETWEEN GRAVES DISEASE AND MYASTHENIA GRAVIS: TWO CASE REPORTS

Case Presentation: Case 1:A 55 year-old woman with a history of myasthenia gravis presented to with symptoms of double vision. She was also complaining of palpitations, weight loss, sweating, and insomnia. She was diagnosed with [...]

By | 2019-03-11T14:35:55+00:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on ASSOCIATION BETWEEN GRAVES DISEASE AND MYASTHENIA GRAVIS: TWO CASE REPORTS

MYASTHENIA GRAVIS THAT MIMICS PRESENTATION OF CEREBRAL VASCULAR ACCIDENT

Case Presentation: An 88-year-old Japanese female with a history of treated breast cancer, palate squamous cell carcinoma and meningioma presented with acute on subacute worsening of left-sided facial droop, dysarthria, and dysphagia. Two weeks prior to admission, [...]

By | 2018-03-19T13:04:58+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on MYASTHENIA GRAVIS THAT MIMICS PRESENTATION OF CEREBRAL VASCULAR ACCIDENT

THE ERA OF IMMUNOTHERAPY IN CANCER: 2 CASE REPORTS OF IMMUNE RELATED ADVERSE EVENTS SECONDARY TO PEMBROLIZUMAB

Case Presentation: Case1: A 72- year old male with a diagnosis of stage four non-small cell Lung carcinoma who was treated with Pembrolizumab, presented two weeks after his first dose with generalized body aches and [...]

By | 2019-03-11T14:34:44+00:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on THE ERA OF IMMUNOTHERAPY IN CANCER: 2 CASE REPORTS OF IMMUNE RELATED ADVERSE EVENTS SECONDARY TO PEMBROLIZUMAB